Oventus Medical Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2015
2016
2017
2018
Net Income before Extraordinaries
-
2,341.10
6,510.10
5,870.50
Depreciation, Depletion & Amortization
-
197.50
615.60
757.60
Other Funds
381.70
-
768.00
-
Funds from Operations
-
2,102.10
5,311.20
4,197.50
Changes in Working Capital
-
598.10
218.90
437.50
Net Operating Cash Flow
75.90
1,504.00
5,530.10
4,635.00
Capital Expenditures
503.30
2,590.40
2,501.80
2,021.60
Purchase/Sale of Investments
-
92.40
-
22.40
Net Investing Cash Flow
503.30
2,682.80
2,501.80
1,999.20
Issuance/Reduction of Debt, Net
-
221.10
-
-
Net Financing Cash Flow
621.70
4,305.00
16,535.00
7,910.70
Net Change in Cash
42.50
118.20
8,487.00
1,246.90
Free Cash Flow
78.90
3,033.70
5,780.00
4,701.90
Change in Capital Stock
240.00
4,083.80
17,303.00
7,910.70
Exchange Rate Effect
-
-
16.10
29.50

About Oventus Medical

View Profile
Address
1 Swann Road
Indooroopilly Queensland (QLD) 4068
Australia
Employees -
Website http://www.oventus.com.au
Updated 07/08/2019
Oventus Medical Ltd. develops oral appliances for the treatment of obstructive sleep disordered and snoring. It offers an oral device under the O2Vent brand. The O2Vent unique design directs the air flow through to the back of the throat, alleviating multiple sites of obstruction including the nose, soft palate and tongue The company was founded by Christopher Patrick Hart in 2012 and is headquartered in Indooroopilly, Australia.